IDXX

IDEXX Laboratories, Inc.

Healthcare
560.36 +13.18 +2.41% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 44.15B
EV 44.53B
Shares Out 78.78M
Revenue (ttm) 4.55B
Net Income 1.14B
Beta —
P/E —
Forward P/E —
EPS (ttm) $14.23
P/S 9.72
P/B 27.44
P/FCF 35.27
P/C 32.26
EV/Sales 9.78
EV/EBITDA 27.70
ROA 33.38%
ROE 71.82%
ROIC 53.3%
Gross Margin 62.45%
Oper. Margin 32.03%
Profit Margin 25.03%
Debt/Eq 0.36
LT Debt/Cap 15.68%
Quick Ratio 0.64
Current Ratio 1.17
Book/sh 20.42
Cash/sh 2.49
Div Yield —
Div TTM —
Payout Ratio —
SMA20 7.01%
SMA50 4.69%
SMA200 -3.33%
Volume 708,810
Avg Volume 592.87K
Rel Volume 1.2
Perf Week 6.95%
Perf Month 9.52%
Perf Quarter -1.25%
Perf Half Y -4.90%
Perf YTD -17.17%
Perf Year -11.81%
Perf 3Y 31.64%
Perf 5Y -12.58%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

IDEXX Laboratories, Inc. is a global diagnostics and software company serving veterinary healthcare, water microbiology and livestock and poultry diagnostics markets. The company…

Name
IDEXX Laboratories, Inc.
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Jonathan J. Mazelsky · President and Chief Executive Officer
Employees
—
IPO Date
2014-11-19
Phone
(207) 556-0300
Address
One IDEXX Drive, Westbrook, ME 04092
Website
www.idexx.com

Key Executives

Name Title FY Pay
Jay Mazelsky President and CEO (Current as of filing date) —
Annette Catino Chief Financial Officer —
Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary —
Michael G. Erickson, PhD Chief Innovation Officer and President, Companion Animal Group Diagnostics —
Jonathan J. Mazelsky President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.